Pfizer Profit Declines 19% After Loss of Lipitor Patent

Pfizer Profit Declines 19% After Loss of Lipitor Patent: With its best-selling drugs losing patent protection, Pfizer is shedding money-making but noncore businesses to focus on pharmaceutical sciences.